BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30838549)

  • 1. Non-invasive Use of Positron Emission Tomography to Monitor Diethyl maleate and Radiation-Induced Changes in System x
    Čolović M; Yang H; Merkens H; Colpo N; Bénard F; Schaffer P
    Mol Imaging Biol; 2019 Dec; 21(6):1107-1116. PubMed ID: 30838549
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Yang H; Jenni S; Colovic M; Merkens H; Poleschuk C; Rodrigo I; Miao Q; Johnson BF; Rishel MJ; Sossi V; Webster JM; Bénard F; Schaffer P
    J Nucl Med; 2017 Mar; 58(3):367-373. PubMed ID: 27789715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influx rate of
    Pitman KE; Alluri SR; Kristian A; Aarnes EK; Lyng H; Riss PJ; Malinen E
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2190-2198. PubMed ID: 31264167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Chirality on the Application of 5-[
    Čolović M; Yang H; Merkens H; Colpo N; Bénard F; Schaffer P
    Mol Imaging Biol; 2020 Aug; 22(4):873-882. PubMed ID: 31792837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional imaging of oxidative stress with a novel PET imaging agent, 18F-5-fluoro-L-aminosuberic acid.
    Webster JM; Morton CA; Johnson BF; Yang H; Rishel MJ; Lee BD; Miao Q; Pabba C; Yapp DT; Schaffer P
    J Nucl Med; 2014 Apr; 55(4):657-64. PubMed ID: 24578242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Evaluation of [
    Colovic M; Yang H; Southcott L; Merkens H; Colpo N; Bénard F; Schaffer P
    J Nucl Med; 2023 Aug; 64(8):1314-1321. PubMed ID: 37116917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET Imaging of L-Type Amino Acid Transporter (LAT1) and Cystine-Glutamate Antiporter (x
    Krys D; Mattingly S; Glubrecht D; Wuest M; Wuest F
    Mol Imaging Biol; 2020 Dec; 22(6):1562-1571. PubMed ID: 32789819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF-I regulates redox status in breast cancer cells by activating the amino acid transport molecule xC-.
    Yang Y; Yee D
    Cancer Res; 2014 Apr; 74(8):2295-305. PubMed ID: 24686172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
    Habib E; Linher-Melville K; Lin HX; Singh G
    Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.
    Linher-Melville K; Nashed MG; Ungard RG; Haftchenary S; Rosa DA; Gunning PT; Singh G
    PLoS One; 2016; 11(8):e0161202. PubMed ID: 27513743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain.
    Ungard RG; Linher-Melville K; Nashed MG; Sharma M; Wen J; Singh G
    Mol Pain; 2019; 15():1744806918822185. PubMed ID: 30799686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xc- inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism.
    Ma MZ; Chen G; Wang P; Lu WH; Zhu CF; Song M; Yang J; Wen S; Xu RH; Hu Y; Huang P
    Cancer Lett; 2015 Nov; 368(1):88-96. PubMed ID: 26254540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells.
    Linher-Melville K; Haftchenary S; Gunning P; Singh G
    Mol Cell Biochem; 2015 Jul; 405(1-2):205-21. PubMed ID: 25896132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of System xc(-) by Pharmacological Manipulation of Cellular Thiols.
    Albano R; Raddatz NJ; Hjelmhaug J; Baker DA; Lobner D
    Oxid Med Cell Longev; 2015; 2015():269371. PubMed ID: 25949770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotracer stereochemistry affects substrate affinity and kinetics for improved imaging of system x
    Greenwood HE; Edwards R; Koglin N; Berndt M; Baark F; Kim J; Firth G; Khalil E; Mueller A; Witney TH
    Theranostics; 2022; 12(4):1921-1936. PubMed ID: 35198080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance.
    Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Cassady K; Aboody KS
    Mol Cancer Res; 2016 Dec; 14(12):1229-1242. PubMed ID: 27658422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the cystine/glutamate exchanger SLC7A11 in retinal pigment epithelial cells by the antipsoriatic drug monomethylfumarate.
    Ananth S; Babu E; Veeranan-Karmegam R; Bozard Baldowski BR; Boettger T; Martin PM
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1592-602. PubMed ID: 23404113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Tumor Redox Status through (
    McCormick PN; Greenwood HE; Glaser M; Maddocks ODK; Gendron T; Sander K; Gowrishankar G; Hoehne A; Zhang T; Shuhendler AJ; Lewis DY; Berndt M; Koglin N; Lythgoe MF; Gambhir SS; Årstad E; Witney TH
    Cancer Res; 2019 Feb; 79(4):853-863. PubMed ID: 30401715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific PET imaging of xC- transporter activity using a ¹⁸F-labeled glutamate derivative reveals a dominant pathway in tumor metabolism.
    Koglin N; Mueller A; Berndt M; Schmitt-Willich H; Toschi L; Stephens AW; Gekeler V; Friebe M; Dinkelborg LM
    Clin Cancer Res; 2011 Sep; 17(18):6000-11. PubMed ID: 21750203
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.